An experimental therapy has shown promise in preclinical models as treatment for an aggressively spreading type of colorectal cancer, according to a new study by Weill Cornell Medicine investigators.
Dec 15, 2022
0
51
(Medical Xpress) -- Loyola University Medical Center surgeons have successfully removed an extremely rare pancreatic tumor from a patient who was only 9 years old.
Jul 9, 2012
0
0
Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling. A countrywide ...
Jun 11, 2013
0
3
One form of pancreatic cancer has a new enemy: a two-drug combination discovered by UF Health researchers that inhibits tumors and kills cancer cells in mouse models.
Sep 22, 2015
0
29
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths in the United States. Not only are therapeutic options ...
May 24, 2021
0
34
Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known as "collateral lethality," which may create new options for development of therapies ...
Jan 18, 2017
0
7
Tumor cells associated with pancreatic cancer often behave like communities by working with each other to increase tumor spread and growth to different organs. Groups of these cancer cells are better than single cancer cells ...
Aug 12, 2015
0
13
The dietary supplement gamma-linoleic acid can inhibit the growth of a subset of pancreatic cancer cells and selectively promote cancer cell death in mice, a Mayo Clinic study has found. The supplement, a fatty acid also ...
Apr 3, 2012
0
1
A new method to treat hyperinsulinemic hypoglycemia has proven highly selective in targeting lesions and effective in slowing tumor growth, according to research published in the November issue of the Journal of Nuclear Medicine. ...
Nov 9, 2020
0
3
(Medical Xpress)—Researchers at the Stanford University School of Medicine have devised an entirely novel way to block biological signaling pathways that, when overactive, lead to many types of cancers. They've done so ...
Apr 22, 2013
0
0
